TEDI project (Trans European Drug Information)

Slides:

Advertisements

Similar presentations

STRATEGIC OBJECTIVES To organize an European network of researchers in social and human sciences thinking collectively on the practical conditions of the.

Advertisements

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.

EUROPEAN PHYSICIANS SOCIAL MEDIA MOBILE November 2014 PETER DE JONG.

Online Sales and Use of Synthetic Cannabinoids Preliminary findings from a Norwegian study Ola Røed Bilgrei Anne Line Bretteville-Jensen SIRUS.

EEGECS Thematic Network WG3 Continuous Education, E-Learning and the European dimension of studies EEGECS Thematic Network WG3 Continuous Education, E-Learning.

Marketing Research Aaker, Kumar, Day Seventh Edition Instructor’s Presentation Slides.

The Open Method of Coordination in the area of Innovation Policy

The next call FP Infrastructures-5. FP Infrastructures-5 Call outline (1) All fields of S&T are covered Publication date: 4 November 2004.

Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.

Aaker, Kumar, Day Eighth Edition Instructor’s Presentation Slides

Annual report 2010: the state of the drugs problem in Europe.

Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.

ESPON Seminar 15 November 2006 in Espoo, Finland Review of the ESPON 2006 and lessons learned for the ESPON 2013 Programme Thiemo W. Eser, ESPON Managing.

Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.

1 RESEARCH INFRASTRUCTURES RESEARCH INFRASTRUCTURES in FP7 EUDET I3 Kickoff meeting, Desy, Hamburg 15-17/2/2006 Presentation by Stefano Fontana, DG Research.

Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.

What Services Are Saying April Shaw March Survey Questions Covered Questions Covered Illicit Drug Use Illicit Drug Use Polydrug Use Polydrug Use.

LOCAL PASS A Local approach towards the reduction of PsychoActive Substance uSe Renée Otte February 5, 2015.

China July 2004 The European Union Programmes for EU-China Cooperation in ICT.

EMCDDA Treatment data collection strategy - progress report May 09 Dagmar Hedrich, on behalf of the TWG Presentation at the meeting of the Scientific Committee,

Future outlook and next steps for ESPON The ESPON 2013 Programme OPEN DAYS Bruxelles, 10 October 2007.

Information support to innovation activities in ICSTI projects  method support  information support  establishing structures for innovation promotion.

© The Concept Factory © Science Link | 2© Science Link 2013  Three calls during Results:  66 applications, companies from 8 countries.

TEDI TEDI Trans European Drug Information Mireia Ventura – Energy control Barcelona Alexander Bücheli – City of Zurich youth counseling Streetwork.

Call for ANS & CEF Panel Members. Make a difference to European Food Safety – Join EFSA’s Scientific Panels!

First European conference on drug supply indicators, , Brussels – Feed-back Chloé Carpentier, Laurent Laniel, EMCDDA 33 rd meeting of the.

NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.

Annual report 2012: the state of the drugs problem in Europe Name, date.

Katowice – the capital city of the Silesia region: Highly urbanized The highest population density in Poland – 4,64 mln people 12 cities with population.

The European Transport Research Alliance - ETRA Prof. G. A. Giannopoulos Chairman, ETRA.

STATE BAR OF TEXAS ADVANCED FAMILY COURSE: 2015 AUGUST 3-6, 2015 SAN ANTONIO, TEXAS.

IN THIS Slide show YOU WILL LEARN ABOUT ALL VERSIONS OF "MS OFFICE"

DRUG CHECKING TUTORIAL

NEW PSYCHOACTIVE SUBSTANCES (NPS) AND HARM REDUCTION

European Monitoring Platform for Mapping of QoS and QoE

Magali Martinez, Agnès Cadet-Taïrou TREND UNIT, OFDT

DRUG CHECKING PROGRAMS AS A HARM REDUCTION STRATEGY

REWG activities in LILIIA MALON REWG Chair Prague

MIREIA VENTURA VILAMALA, PhD

DR. Fernando Caudevilla Energy control (ABD)

PMMA (paramethoxymethamphetamine) in “legal highs” in Spain

A&M Workplan Objectives

EUROPEAN RAPTOR BIOMONITORING FACILITY

WG1: RELIABLE, ECONOMIC AND EFFICIENT SMART GRID SYSTEM

Davor Kozmus, MHEST Steering Platform Meeting 29. October 2009, Zagreb

Professor Paul I Dargan

The social epidemiology of alcohol and drug use among Israeli school-aged children: Recent developments and current challenges Prof. Yossi Harel-Fisch.

New Psychoactive Substances (NPS) in Deep Web Marketplaces (DWM):

Results of an international drug testing service for cryptomarket users Mireia Ventura· ABD – Energy Control 15th May 2017.

The European Experience: Prescription Drug Misuse in France, Germany, Italy and Spain 24 October 2017 Presented at Lisbon Addictions 2017 Jody L. Green,

Dan Tofan | Expert in NIS 21st Art. 13a WG| LISBON |

Ludmila Carapinha, Catarina Guerreiro

Symptoms and correlates of emergency medical treatment following the use of MDMA Dr. Larissa J. Maier Monica J. Barratt, Jason A. Ferris, & Adam R. Winstock.

Comparison of data from WBE with other sources

A Spanish Drug Checking service for recreational drug users

Daughter Groundwater Directive

Temporary Capacity Restrictions: TCR WG & TCR tool

The ERA.Net instrument Aims and benefits

WWater reuse Water Directors 24/11/2014 Nicola NOTARO

Non-fatal poisoning with illicit drugs in Denmark

SOCIAL DIALOGUE WITHIN EUPAN

Legalization of Drugs The Dutch experience.

Andreja Drev, National Institut of Public Health, Slovenia

S.A.M.P.L.E. Small Area Methods for Poverty and Living condition Estimates Siena, Sample 6 October 2010 Some results from the survey on local stakeholders.

LNG Workshop Bilbao, March 13th 2009 GLE.

The Fundamental Importance of Youth Work Recommendation CM/Rec(2017)4 of the Committee of Ministers to Member States on Youth Work Ms Antje Rothemund,

LOOK-A-LIKE DRUGS MR. GARDNER HEALTH.

WWater reuse SCG Water Reuse 1/10/2014 Dagmar BEHRENDT KALJARIKOVA

Skopje, 21 November 2017, General Population Survey results– launch

Risk Reduction on New Drugs,

Presentation transcript:

TEDI project (Trans European Drug Information) Berlin, 9th of November 2017 Mireia Ventura PhD TEDI manager

Definition The term “Drug Checking” (DC) refers to an integrated service that basically enables drug users to have their drugs bought on the grey or black market (e.g., cocaine, ecstasy, GHB, or LSD) chemically analysed as well as to receive advices and - if necessary - consultation and counseling. Other terms as are used: Drug Testing, Pill Testing, Testing, Pill Checking. TEDI propose as standard the name of Drug Checking

Drug Checking in Europe In TEDI were included seven European countries offering Drug Checking facilities that generate around 14.000 samples every year.

Definition TEDI project The Trans European Drug Information project (TEDI) is a network of European fieldwork Drug Checking services that share their expertise and data within a European monitoring and information system. TEDI’s chief aim is to improve public health and intervention programs, improving the knowledge, the diffusion and the best practices of the all groups of drug checking. TEDI has developed a database system that collects, monitors and analyses the evolution of various European drug trends in recreational settings.

TEDI’s database 16.449 samples from 5 different groups working in the field with Drug Checking 458 different substances inside TEDI’s database 210 synthetic drugs inside

TEDI’s database

TEDI’s Trend Reports (TTR) 1st TTR: July 2012 2nd TTR: January 2013 3rd TTR: August 2013

Scientific article of TEDI project

Type of drugs analysed by TEDI members (2008-2013)

Evolution of MDMA (2008-2013)

Evolution of cocaine and amphetamine (2008-2013)

Scientific article of TEDI project 60 NPS detected were new for TEDI members during these 3 years of project

New European Drug Checking services are appearing…

Type of drugs analysed from 2014 to 2016

Analysis of MDMA 2014-2016

TRENDS IN NPS There is an increasing trend of NPS used as an adulterant in classic drugs 10% of samples (DIMS 2016) Powerful substances such as alpha-PVP (EC 2017) Increase in variety of NPS detected LEGAL HIGH INHALTSSTOFFE (2016) 9 designer Benzodiazepines 12 synthetic Opioids In herbal mixtures most relevant ingredient is CUMYL-PeGACLONE

THANKS FOR YOUR ATTENTION! www.safernightlife.org/tedi mireia@energycontrol.org